Metabolism of chloroform in the human liver and identification of the competent P450s

Drug Metabolism and Disposition

Volumn 31, Issue 3, 2003, Pages 266-274

  Gemma, Simonetta ^a   Vittozzi, Luciano ^a   Testai, Emanuela ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

4 METHYLPYRAZOLE; ANTIBODY; CHLOROFORM; CHLORZOXAZONE; COMPLEMENTARY DNA; COUMARIN; COUMARIN 7 HYDROXYLASE; CYTOCHROME P450; CYTOCHROME P450 2A6; CYTOCHROME P450 2E1; RADICAL;

AEROBIC METABOLISM; ARTICLE; CATALYSIS; CATALYST; ENVIRONMENTAL FACTOR; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME KINETICS; HUMAN; HYDROXYLATION; LIVER MICROSOME; METABOLISM; OXIDATION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REACTION OPTIMIZATION; REDUCTION;

BIOTRANSFORMATION; CELL LINE, TRANSFORMED; CHLOROFORM; CYTOCHROME P-450 ENZYME SYSTEM; HUMANS; ISOENZYMES; MICROSOMES, LIVER; OXIDATION-REDUCTION;

EID: 0037371288     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: 10.1124/dmd.31.3.266     Document Type: Article

References (40)

1. Ade P, Guastadisegni C, Testai E, and Vittozzi L (1994) Multiple activation of chloroform in kidney microsomes from male and female DBA/2J mice. J Biochem Toxicol 9:289-295.
2. Backer LC, Ashley DL, Bonin MA, Cardinali FL, Kieszak SM, and Wooten JV (2000) Household exposure to drinking water disinfection by-products: whole blood trihalomethane levels. J Expo Anal Environ Epidemiol 10:321-326.
3. Branchflower RV, Schulick RD, George JW, and Pohl LR (1983) Comparison of the effects of methyl-N-butyl ketone and phenobarbital on rat liver cytochrome P-450 and the metabolism of chloroform to phosgene, Toxicol Appl Pharmacol 71:414-421.
4. Brzezinski MR, Boutelet-Bochan H, Person RE, Fantel AG, and Juchau MR (1999) Catalytic activity and quantitation of cytochrome P-450 2E1 in prenatal human brain. J Pharmacol Exp Ther 289:1648-1653.
5. Cantor KP, Lynch CF, Hidelsheim ME, Dosemeci M, Lubin J, Alavanja M, and Craun G (1998) Drinking water source and chlorination byproducts. I. Risk of bladder cancer. Epidemiology 9:21-28.
6. Constan AA, Sprankle CS, Peters JM, Kedderis GL, Everitt JI, Wong BA, Gonzalez FJ, and Butterworth BE (1999) Metabolism of chloroform by cytochrome P450 2E1 is required for induction of toxicity in the liver, kidney and nose in male mice. Toxicol Appl Pharmacol 160:120-126.
7. 3 metabolites to microsomal phospholipids, Chem Biol Interact 85:229-242.
8. Folch J, Lees M, and Sloane-Stanley GM (1957) A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226:497-509.
9. Frank H, Haussmann HJ, and Remmer H (1982) Metabolic activation of carbon tetrachloride: induction of cytochrome P450 with phenobarbital or 3-methylcholanthrene and its effect on covalent binding. Chem-Biol Interact 40:193-208.
10. Fry BJ, Taylor T, and Hathway DE (1972) Pulmonary elimination of chloroform and its metabolite in man. Arch Int Pharmacodyn Ther 196:98-111.
11. Gallagher MD, Nuckols JR, Stallones L, and Savitz DA (1998) Exposure to trihalomethanes and adverse pregnancy outcomes. Epidemiology 9:484-489.
12. Gemma S, Ade P, Sbraccia M, Testai E, and Vittozzi L (1996) In vitro quantitative determination of phospholipid adducts of chloroform intermediates in hepatic and renal microsomes from different rodent strains. Environ Toxicol Pharmacol 2:233-242.
13. Gottlieb MS, Carr JK, and Morris DT (1981) Cancer and drinking water in Louisiana: colon and rectum. Int J Epiodemiol 10:117-125.
14. Guo Z, Raeissi S, White RB, and Stevens JC (1997) Orphenadrine and methimazole inhibit multiple cytochrome P450 enzymes in human liver microsomes. Drug Metab Dispos 25:390-393.
15. Hidelsheim ME, Cantor KP, Lynch CF, Dosemeci M, Lubin J, Alavanja M, and Craun G (1998) Drinking water sources and chlorination byproducts. II. Risk of colon and rectal cancers. Epidemiology 9:29-35.
16. Hogan MD, Chi PY, Hoel DG, and Mitchell TJ (1979) Association between chloroform levels in finished drinking water supplies and various site-specific cancer mortality rates. J Environ Pathol Toxicol 2:873-887.
17. IPCS (1994) Environmental Health Criteria 163: Chloroform, World Health Organization, Geneva, Switzerland.
18. Jorgenson TA, Meierhenry EF, Rushbrook CJ, Bull RJ, and Robinson M (1985) Carcinogenicity of chloroform in drinking water to male Osborne Mendel rats and female B6C3F1 mice. Fundam Appl Toxicol 5:760-769.
19. Kharasch ED, Hankins DC, Mautz D, and Thummel KE (1996) Identification of the human enzyme responsible for halothane metabolism: implications for the prevention of halothane hepatitis. Lancet 347:1367-1371.
20. Kharasch ED and Thummel KE (1993) Identification of cytochrome P4502E1 as the predominant enzyme catalyzing human liver microsomal defluorination of sevoflurane, isoflurane and methoxyflurane. Anesthesiology 79:795-807.
21. Lavigne JG and Marchand C (1974) The role of metabolism in chloroform hepatotoxicity. Toxicol Appl Pharmacol 29:312-326.
22. Mansuy D, Beaune P, Cresteil TH, Lange M, and Leroux JP (1977) Evidence for phosgene formation during liver microsomal oxidation of chloroform. Biochem Biophys Res Commun 79:513-517.
23. NCI (1976) Report on Carcinogenesis Bioassay of Chloroform (National Technical Information Service PB-264018/AS). National Cancer Institute, Bethesda, MD.
24. Omura T and Sato R (1964) The carbon monoxide binding pigment of liver microsomes. J Biol Chem 239:2370-2378.
25. Oyama VI and Eagle H (1956) Measurement of cell growth in tissue culture with a phenol reagent (Folin-Ciocalteus). Proc Soc Exp Biol Med 91:305-307.
26. Pohl LR, Bhooshan B, Whittaker NF, and Krishna G (1977) Phosgene: a metabolite of chloroform. Biochem Biophys Res Commun 79:684-691.
27. Pohl LR, Branchflower RV, Highet RJ, Martin JL, Nunn DS, Monks TJ, George JW, and Hinson JA (1981) The formation of diglutathionyl dithiocarbonate as a metabolite of chloroform, bromotrichloromethane and carbon tetrachloride. Drug Metah Dispos 9:334-339.
28. Rouser G, Siakotos AN, and Fleischer S (1966) Quantitative analysis of phospholipids by thin-layer chromatography and phosphorus analysis of spots. Lipids 1:85-89.
29. Sato A, Nakajima T, and Koyama Y (1980) Effects of chronic ethanol consumption on hepatic metabolism of aromatic and chlorinated hydrocarbons in rats. Br J Ind Med 37:382-386.
30. Spracklin DK, Thummel KE, and Kharasch ED (1996) Human reductive halothane metabolism in vitro is catalyzed by cytochrome P450 2A6 and 3A4. Drug Metab Dispos 24:976-983.
31. 2H)-chloroform. Chem-Biol Interact 37:207-217.
32. Testai E, De Curtis V, Gemma S, Fabrizi L, Gervasi PG, and Vittozzi L (1996) The role of different cytochrome P-450 isoforms in in vitro chloroform metabolism. J Biochem Toxicol 11:305-311.
33. Testai E, Di Marzio S, Di Domenico A, Piccardi A, and Vittozzi L (1995) An in vitro investigation of the reductive metabolites of chloroform. Arch Toxicol 70:83-88.
34. Testai E, Di Marzio S, and Vittozzi L (1990) Multiple activation of chloroform in hepatic microsomes from uninduced B6C3F1 mice. Toxicol Appl Pharmacol 104:496-503.
35. Testai E, Keizer J, Pacifici GM, and Vittozzi L (1991) Chloroform bioactivation by microsomes from colonic and ileal mucosa of rat and man. Toxicol Lett 57:19-27.
36. Tomasi A, Albano E, Biasi F, Slater TF, Vannini V, and Dianzani MU (1985) Activation of chloroform and related trihalomethanes to free radical intermediates in isolated hepatocites and in the rat in vivo as detected by the ESR-spin trapping technique, Chem-Biol Interact 55:303-316.
37. Vittozzi L, Gemma S, Sbraccia M, and Testai E (2000) Comparative characterization of chloroform metabolism and toxicokinetics in rodent strains differently susceptible to chloroform carcinogenicity, Environ Toxicol Pharmacol 8:103-110.
38. Wallace LA (1997) Human exposure and body burden for chloroform and other trihalomethanes. Crit Rev Environ Sci Technol 27:113-194.
39. Waller K, Swan SH, DeLorenze G, and Hopkins B (1998) Trihalomethanes in drinking water and spontaneous abortion. Epidemiology 9:134-140.
40. Zangar RC, Benson JM, Burnett VL, and Springer DL (2000) Cytochrome P450 2E1 is the primary enzyme responsible for low-dose carbon tetrachloride metabolism in human liver microsomes. Chem-Biol Interact 125:233-243.